Adrenergic Drugs Flashcards
Synthesis of NT in Adrenergic nerve terminal
- tyrpsine is actively transported into nerve endings
- is converted into DOPA by tyrosine hydroxyls (Rate-limiting step)
- DOPA is converted to dopamine by DOPA decarboxylase
- DA is metabolized to NE via Dopamine beta decarboxylase
- NE is taken up & stored in granules; NE not stored in granules is called the mobile pool–this can be inactivated by MAO
During depolarization, Ca2+ enters the presynaptic terminal via the voltage-dependent Ca channels–>degranulation of storage vesicles–>NE released via exocytosis into synaptic junction
Actions:
- NE can activate pre junctional receptors = alpha 2 receptors (feedback regulation system–>inhibition of further release)
- can activate postsynaptic receptors (alpha 1 & beta 1-3 receptors)
Termination of NE action
- mainly by reuptake (via NET= NE transporter)
2. Diffusion away from receptor site with eventual metal by catechol-o-methyl transferase (COMT) in plasma or liver
MAO inhibitors
increase the pre junctional levels of NE
Displacers
indirect acting sympathomimetics displace the stored NE
uptake inhibitors
indirect actinv sympathomimetics inhibit the uptake into nerve cell–>increases post junctional levels/actions of NE
alpha 2 receptor
pre-synaptic autoreceptor
coupled to G2–>inhibition of adenyl cyclase–>decrease cAMP
D1 receptors
activates adenyl cyclase–>increases cAMP
alpha 1 receptors
coupled to Gq–>stimulates PLC–>activates IP3 & DAG pathway
beta receptors
coupled to Gs–>activation of adenyl cyclase–>increased cAMP
Things that affect PVR
alpha 1: vasoconstriction–>increase TPR–>Increase BP
beta 2: vasodilation–>decrease TPR–>decrease diastolic BP
alpha 1 receptor locations & actions
- most vascular smooth muscle–>vasoconstriction–> Increase TPR & Increase BP
- Pupillary dilator muscle–>contraction–>dilates pupil
- Prostate (ductus deferens & seminal vesicles)–> contraction–>ejaculation
alpha 2 receptor locations & actions
- postsynaptic CNS adrenoceptors–>probably multiple
- presynaptic nerve terminals–>inhibition of NT release–> decrease sympathetic outflow
- some vascular smooth muscle (nasal mucosa)–> nasal decongestion
- fat cells–> inhibition of lipolysis
beta 1 receptor locations & actions
- heart–> increase F & rate of contraction
2. juxtaglomerular cells–> increase renin release
beta 2 receptor locations & actions
- bronchial relaxation–>bronchodilation
- uterine relaxation
- vascular bed in skeletal muscle
vasodilation–>decrease TPR
- skeletal muscle–>promotes K uptake
- human liver–>activates glycogenolysis
- increase pancreas insulin secretion
beta 3 receptor locations & actions
Fat cells–>activates lipolysis
D1 receptor locations & actions
dilates renal bv
D2 receptor locations & actions
nerve endings–> modulates NT release
Indirect agonist types:
- act via displacement of stored catecholamines from adrenergic nerve ending
ex) amphetamine & tyramine - act via inhibition of repute of catecholamines already released
ex) cocaine & TCAs
some drugs may have direct & indirect actions
Indirect acting adrenergic agonists
- tyramine
- amphetamine
- ephedrine*
- metaraminol*
1-4 increase release of NE - cocaine (blocks reuptake
Nonspecific Adrenergic Agonists
- NE: a1=a2, B1»B2
- Epi: a1=a2=b1=b2
- Dopamine: D1=D2>B1»a
- Ephedrine: a1=a2=b1=b2
a1=a2=b1=b2
Epi & Ephedrine
alpha 1 agonists
- phenylephrine
- methoxamine
- metaraminol
alpha 2 agonists
clonidine
non-specific beta agonists
isoproterenol; B1=B2
beta 1 agonists
dobutamine
beta 2 agonists
- terbutaline*
- albuterol*
- metaproterenol
- ritodrine*
NE
non-specific adrenergic agonist: a1=a2; B1»B2
Fendolopam
D1 agonist
Adrenergic effect on BV
a1 –>
B2–>
a1–> increases arterial resistance
b2–>promote sm relaxation–>decrease arterial resistance
skin & splanchnic vessels have predominantly alpha receptors & constrict in the presence of Epi & NE
Adrenergic effect on Heart
- direct effects via B1 receptors–>increased Ca influx into cardiac cells = Pacemaker activity increased (+ chronotropic effect)
- conduction velocity in AV node increased
- intrinsic contractility is increased (+ inotropic effect)
Beta & alpha receptors in pancreatic islets
b receptors–>increase insulin secretion
alpha2 receptors–>decrease insulin secretion
Effect of Insulin
- Increased glycogen synthesis: insulin forces storage of glucose in liver (and muscle) cells in the form of glycogen; 2. lowered levels of insulin cause liver cells to convert glycogen to glucose and excrete it into the blood.
+ inotropic effect
intrinsic contractility increased
+ chronotropic effect
pacemaker activity increased
Phenylephrine effect on BP
alpha 1–>increase TPR –> Increase BP
also decreases venous capacitance
this leads to a dose-dependent rise in BP
Stimulation of B1 receptors in heart
increase CO & BP
Affect of stimulation of b2 receptors on BP
decrease peripheral resistance via vasodilation in certain vascular beds
Isoproterenol effect on CO & BP
increase CO; decrease peripheral resistance by activating B2 receptors
lowers BP via B2; raises HR via B1
Phenylephrine effect on BP & HR
raises BP (via alpha 1 receptors) but not HR bc no effect on beta receptors
Epi effect on BP & HR
increases BP & HR
antimuscarinics vs alpha 1 effect on eye
alpha 1–>only mydriasis, no cycloplegia
antimuscarinics–>cycloplegia
increased alertness, reduced fatigue, anorexia, euphoria, insomnia
effect of non-catecholamines (i.e. amphetamines) on CNS
in very high doses: aggressiveness, marked anxiety, convulsions
catecholamines don’t enter CNS
effect of stimulating receptors located on radial pupillary dilator muscle of iris
alpha receptors; stimulation–>mydriasis (dilation)
phenylephrine use
used as mydriatic for retinoscopy
epinephrine use in glaucoma
non-selective agonist used to increase the outflow of aqueous humor via uveocleral veins (obsolete) in treating glaucoma
apraclonidine use
alpha 2 selective agonist used to decrease aqueous secretion in the treatment of glaucoma
brimonidine use
alpha 2 selective agonist used to decrease aqueous secretion in the treatment of glaucoma
timolol
beta antagonist used to treat glaucoma: decrease the production of aqueous humor
(affects beta receptors in ciliary body)
beta 2 receptor stimulation in bronchial smooth muscle:
effect & use
bronchodilation; used to treat bronchial asthma
Adrenergic affects on Respiratory tract
- decongestant action of adrenoreceptor stimulants (via alpha receptors)
- B2–>bronchodilation of bronchial sm
Adrenergic affects on GU tract
- B2 receptors in uterus–>relaxation; used in premature labor
- alpha1A receptors in bladder base, urethral sphincter & prostate mediate contraction–>promotes urinary continence
- B2 receptors in bladder wall–>relaxation
- alpha receptor activation in ductus deferens, seminal vesicles & prostate –>ejaculation